For example, in breast cancer, the presence of EMT markers such as vimentin and N-cadherin, as well as drivers of EMT, such as Snail and Twist, is associated with an aggressive phenotype and poor clinical outcomes [92]. This evidence concerns the gene VIM and breast carcinoma.